Skip to main navigation

Ocugen, Inc.

Pursuing Innovative Ocular Biotherapeutics

Ocugen, Inc.
  • About
    +
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Founders
  • Vaccine
    +
    • Vaccine Overview
    • Scientific Advisory Board
    • Publications
  • Pipeline
    +
    • Pipeline Overview
    • Modifier Gene Therapy Platform
    • OCU400
    • OCU410
    • OCU200
    • COVAXIN™
  • News
    +
    • News
    • Events
    • Press Releases
  • Investors
    +
    • Investor Overview
    • Stock Information
      +
      • Historic Price Lookup
      • Investor Calculator
      • Analyst Coverage
    • Financial Information
      +
      • SEC Filings
      • Financial Reports
      • Quarterly Reports
    • Presentations
    • Corporate Governance
    • Investor Resources
      +
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Contact
Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 17, 2021
Document Date
Mar 16, 2021
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Ocugen, Inc.
Issuer
Ocugen, Inc.

Filing Formats

View HTML
Download PDF
Download DOC

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Ocugen, Inc.

Ocugen, Inc.

  • 263 Great Valley Parkway
    Malvern, PA 19355
  • 484.328.4701

Quick Links

  • About
  • News
  • Events
  • Press
  • Pipeline
  • Investors
  • Careers
  • Contact

Keep In Touch


© 2021 Ocugen, Inc. All Rights Reserved.